Snodgrass H. Ralph
- SEC CIK
- 0001415876
No open-market purchases or sales filed in the past year.
Current role at each company
- VTGN Vistagen Therapeutics, Inc.PRES./CHIEF SCIENTIFIC OFFICERas of Jan 3, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Snodgrass H. Ralph as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2021 (view filing) | Aug 17 | 1 day | Snodgrass H. RalphPRES./CHIEF SCIENTIFIC OFFICER | PPurchase | +3.75K | $2.73 | +$10.2K | +12.1%34.6K after |